Carfilzomib Combined with Thalidomide and Dexamethasone (CTD) Is an Highly Effective Induction and Consolidation Treatment in Newly Diagnosed Patients with Multiple Myeloma (MM) Who Are Transplant Candidate

被引：0

作者：

Sonneveld, Pieter ^{[1
]}

Asselbergs, Emilie ^{[1
]}

Zweegman, Sonja ^{[2
]}

Van der Holt, Bronno ^{[3
]}

Kersten, Marie Jose ^{[4
]}

Vellenga, Edo ^{[5
]}

van Marwijk-Kooy, Marinus ^{[6
]}

de Weerdt, Okke ^{[7
]}

Lonergan, Sarah

Lokhorst, Henk ^{[8
]}

机构：

[1] Erasmus MC, Rotterdam, Netherlands

[2] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands

[3] Erasmus Univ, Med Ctr, HOVON Data Ctr, Rotterdam, Netherlands

[4] AMC, Amsterdam, Netherlands

[5] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands

[6] Isala Clin, Zwolle, Netherlands

[7] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands

[8] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands

来源：

关键词：

D O I：

10.1182/blood.V120.21.333.333

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

333

引用

页数：2